Published online August 18, 2008
doi:10.1084/jem.20080414
The Journal of Experimental Medicine, Vol. 205, No. 9, 2139-2149
The Rockefeller University Press, 0022-1007 $30.00
© 2008 Jaensson et al.
Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans
Elin Jaensson1,
Heli Uronen-Hansson1,
Oliver Pabst2,
Bertus Eksteen3,
Jiong Tian4,
Janine L. Coombes5,
Pia-Lena Berg6,
Thomas Davidsson7,
Fiona Powrie5,
Bengt Johansson-Lindbom1, and
William W. Agace1
1 Immunology Section, BMC D14, 221 84 Lund University, Lund, Sweden
2 Institute of Immunology, Hannover Medical School, 30625 Hannover, Germany
3 Liver Research Group, Medical Research Council Centre for Immune Regulation, Institute of Biomedical Research, University of Birmingham Medical School, Birmingham, England, UK
4 Department of Visceral and Transplantation Surgery, Hannover Medical School, 30625 Hannover, Germany
5 Sir William Dunn School of Pathology, University of Oxford, Oxford, England, UK
6 Department of Surgery and 7 Department of Urology, Lund University Hospital, 221 85 Lund, Sweden
CORRESPONDENCE William Agace: William.Agace{at}med.lu.se
A functionally distinct subset of CD103+ dendritic cells (DCs) has recently been identified in murine mesenteric lymph nodes (MLN) that induces enhanced FoxP3+ T cell differentiation, retinoic acid receptor signaling, and gut-homing receptor (CCR9 and
4β7) expression in responding T cells. We show that this function is specific to small intestinal lamina propria (SI-LP) and MLN CD103+ DCs. CD103+ SI-LP DCs appeared to derive from circulating DC precursors that continually seed the SI-LP. BrdU pulse-chase experiments suggested that most CD103+ DCs do not derive from a CD103– SI-LP DC intermediate. The majority of CD103+ MLN DCs appear to represent a tissue-derived migratory population that plays a central role in presenting orally derived soluble antigen to CD8+ and CD4+ T cells. In contrast, most CD103– MLN DCs appear to derive from blood precursors, and these cells could proliferate within the MLN and present systemic soluble antigen. Critically, CD103+ DCs with similar phenotype and functional properties were present in human MLN, and their selective ability to induce CCR9 was maintained by CD103+ MLN DCs isolated from SB Crohn's patients. Thus, small intestinal CD103+ DCs represent a potential novel target for regulating human intestinal inflammatory responses.
Abbreviations used: LP, lamina propria; MLN, mesenteric LN; pOVA, OVA peptide; PP, Peyer's patch; RA; retinoic acid; RAR, retinoic acid receptor; SI, small intestine; SI-LP, small intestinal LP; SILT, solitary isolated lymphoid tissue.
© 2008 Jaensson et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?